Lundbeck
HLUN-B.CO
#2420
Rank
S$8.19 B
Marketcap
$8.56
Share price
3.98%
Change (1 day)
22.26%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Market capitalization of Lundbeck (HLUN-B.CO)

Market cap: S$8.19 Billion

As of November 2024 Lundbeck has a market cap of S$8.19 Billion. This makes Lundbeck the world's 2420th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lundbeck from 2005 to 2024

End of year Market Cap

Year Marketcap Change
2024S$8.19 B31.98%
2023S$6.21 B28.22%
2022S$4.84 B421.81%
2021S$0.92 B-23.85%
2020S$1.21 B-10.84%
2019S$1.36 B-13.98%
2018S$1.58 B-12.01%
2017S$1.80 B15.11%
2016S$1.56 B21.69%
2015S$1.28 B84.59%
2014S$0.69 B-17.31%
2013S$0.84 B78.85%
2012S$0.47 B-44.75%
2011S$0.85 B33.59%
2010S$0.64 B-7.15%
2009S$0.68 B-19.9%
2008S$0.86 B-18.3%
2007S$1.05 B-11.16%
2006S$1.18 B15.07%
2005S$1.03 B

End of Day market cap according to different sources

On Nov 12th, 2024 the market cap of Lundbeck was reported to be:

S$7.87 Billion
by Yahoo Finance info icon info icon
S$7.87 Billion
by CompaniesMarketCap info icon info icon